文献速递免疫规划卫生政策与健康促进传染病防控与疫情报告

资源有限地区流感疫苗接种风险人群优先排序:南非案例研究

Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa.
PubMed 文献 · Vaccine · 2018-11-22

南非通过收集本地疾病负担与疫苗效力数据,采用公式估算各风险人群疫苗接种可避免的住院或死亡及成本,发现孕妇、HIV感染成人和结核病成人与儿童住院避免数较高,老年死亡避免数最高,但结核、HIV和孕妇每结局避免成本最低。

要点

  • 孕妇、HIV感染成人及结核病成人和儿童每10万接种者避免住院数最高。
  • 65岁及以上成人每10万接种者避免死亡数最高。
  • 结核、HIV和孕妇每避免住院日及每挽救生命年成本最低。

核心结论

  • 评估疫苗可避免疾病结局及相关成本有助于资源有限地区决策者确定流感疫苗风险人群优先顺序。

研究设计与样本

  • 收集南非本地已发表和未发表的疾病负担数据及风险人群与健康成人疫苗效力数据,采用公式估算各风险人群疫苗避免疾病。

主要发现

  • 孕妇、HIV感染成人及结核病成人和儿童每10万接种者避免住院数最高。
  • 65岁及以上成人每10万接种者避免死亡数最高。
  • 每避免住院日成本范围USD148-1,344,每挽救生命年成本范围USD112-1,230。

关键数值与推荐

  • 疫苗避免疾病估算公式:每10万人流感相关住院(或死亡)率乘以流感疫苗效力。
  • 结核病成人和儿童、HIV感染成人及孕妇每结局避免成本最低。

临床怎么用

  • 决策者可结合本地疾病负担、疫苗效力和成本数据,优先为孕妇、HIV感染者、结核病患者及老年人接种流感疫苗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Due to competing health priorities, low- and middle-income countries (LMIC) may need to prioritize between different influenza vaccine risk groups. Risk group prioritization may differ in LMIC based upon programmatic feasibility, country-specific prevalence of risk conditions and influenza-associated morbidity and mortality. METHODS: In South Africa, we collected local disease burden data (both published and unpublished) and published vaccine efficacy data in risk groups and healthy adults. We used these data to aid policy makers with risk group prioritization for influenza vaccination. We used the following formula to assess potential vaccine averted disease in each risk group: rate of influenza-associated hospitalization (or death) per 100,000 population * influenza vaccine efficacy (VE). We further estimated the cost per hospital day averted and the cost per year of life saved by influenza vaccination. RESULTS: Pregnant women, HIV-infected adults, and adults and children with tuberculosis disease had among the highest estimates of hospitalizations averted per 100,000 vaccinated and adults aged 65 years and older had the highest estimated deaths averted per 100,000 vaccinated. However, when assessing both the cost per hospital day averted (range: USD148-1,344) and the cost per year of life saved (range: USD112-1,230); adults and children with TB disease, HIV-infected adults and pregnant women had the lowest cost per outcome averted. DISCUSSION: An assessment of the potential disease outcomes averted and associated costs may aid policymakers in risk group prioritization for influenza vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. McMorrow ML, Tempia S, Walaza S, et al. Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa. Vaccine. 2018. PMID: 30471956. doi:10.1016/j.vaccine.2018.11.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。